Azelnidipine

阿折地平

Report date: 2026/03/17 16:11:55
NME

Base Information

Drug NameAzelnidipine
Drug Alias Name阿泽地平azelnidipinoAzelnidipinumCalblockCS-905 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated L-type calcium channel blockers
TargetsVoltage-gated L-type calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryJapan
Original Approved Date2003/01/31
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co LtdNanjing Zhengda Tianqing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC08CA
Related LinksWikipediaDrugBankKEGG